Deutsche Bank Ag\ Uni Qure N.V. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Uni Qure N.V. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 420,689 shares of QURE stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

420,689

Previous 420,689 -0.0%

Holding current value

$2.4 Million

Previous $1.88 Million 10.03%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $1.85 Million - $2.28 Million	420,689 New	420,689 $1.88 Million
Q3 2023 Nov 09, 2023	SELL	$6.71 - $11.83 $4,851 - $8,553	-723 Reduced 0.48%	148,725 $997,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $556 - $1,110	-50 Reduced 0.03%	149,448 $1.71 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $66,254 - $81,737	-3,543 Reduced 2.32%	149,498 $3.01 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $578,825 - $872,710	31,944 Added 26.38%	153,041 $3.47 Million
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $29,748 - $44,746	-1,752 Reduced 1.43%	121,097 $2.27 Million
Q2 2022 Aug 11, 2022	BUY	$13.15 - $20.45 $269,890 - $419,715	20,524 Added 20.06%	122,849 $2.29 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $727,000 - $1.08 Million	50,000 Added 95.56%	102,325 $1.85 Million
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $227,699 - $405,112	11,250 Added 27.39%	52,325 $1.09 Million
Q3 2021 Nov 04, 2021	BUY	$26.01 - $38.22 $107,317 - $157,695	4,126 Added 11.17%	41,075 $1.32 Million
Q2 2021 Aug 11, 2021	BUY	$29.97 - $37.17 $296,043 - $367,165	9,878 Added 36.49%	36,949 $1.14 Million
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $1.16 Million - $1.67 Million	-39,651 Reduced 59.43%	27,071 $912,000
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $1.39 Million - $1.99 Million	39,243 Added 142.81%	66,722 $2.41 Million
Q3 2020 Nov 12, 2020	SELL	$35.98 - $47.66 $1.32 Million - $1.75 Million	-36,796 Reduced 57.25%	27,479 $1.01 Million
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $2.09 Million - $3.14 Million	-46,310 Reduced 41.88%	64,275 $2.9 Million
Q1 2020 May 14, 2020	BUY	$40.01 - $73.97 $3.15 Million - $5.82 Million	78,667 Added 246.47%	110,585 $5.25 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $206,442 - $414,887	-5,560 Reduced 14.84%	31,918 $2.29 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $2.94 Million - $5.74 Million	-74,711 Reduced 66.59%	37,478 $1.47 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $2.22 Million - $3.47 Million	42,170 Added 60.23%	112,189 $8.77 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $1.92 Million - $4.79 Million	70,019 New	70,019 $4.18 Million
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $128,341 - $190,991	-5,629 Closed	0 $0
Q3 2018 Dec 21, 2021	BUY	$29.75 - $43.08 $158,389 - $229,357	5,324 Added 1745.57%	5,629 $205,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $356,256 - $515,883	-11,975 Reduced 97.52%	305 $10,000
Q2 2018 Apr 21, 2020	BUY	$21.96 - $39.94 $126,797 - $230,613	5,774 Added 88.75%	12,280 $464,000
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $60,631 - $110,274	2,761 Added 73.72%	6,506 $245,000
Q1 2018 Oct 18, 2019	BUY	$17.1 - $26.61 $63,868 - $99,388	3,735 Added 37350.0%	3,745 $87,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $5,540 - $8,621	-324 Reduced 97.01%	10 $0
Q4 2017 Feb 14, 2018	SELL	$9.47 - $19.59 $1.6 Million - $3.31 Million	-168,722 Reduced 99.8%	334 $6,000
Q3 2017 Nov 14, 2017	BUY	$7.7 - $9.6 $1.3 Million - $1.62 Million	169,056	169,056 $1.62 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account